| Oct 10 |
JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc
|
| Sep 23 |
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
|
| Sep 13 |
Intra-Cellular Therapies (NASDAQ:ITCI) delivers shareholders fantastic 54% CAGR over 5 years, surging 3.9% in the last week alone
|
| Sep 6 |
Piper Sandler ups Intra-Cellular to overweight, cites Caplyta potential
|
| Sep 6 |
Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report?
|
| Sep 5 |
Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
| Sep 4 |
Peaking Back In On Intra-Cellular Therapies
|
| Aug 28 |
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
|
| Aug 17 |
Here's Why We're Not At All Concerned With Intra-Cellular Therapies' (NASDAQ:ITCI) Cash Burn Situation
|
| Aug 8 |
Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon
|
